Skip to main content
. Author manuscript; available in PMC: 2009 Oct 15.
Published in final edited form as: Clin Cancer Res. 2008 Sep 15;14(18):5900–5906. doi: 10.1158/1078-0432.CCR-08-0846

Table 1.

Gene Regulation in PBMCs from normal donors following 1hr IFN-α treatment in vitro

Gene Function Fold Change Post vs Pre- treatment
Chemokine (C-X-C motif) ligand 10(CXCL10) Chemotaxis, stimulates NK cells and monocytes 176.1
Chemokine (C-C motif) ligand 8(CCL8) Chemotaxis 122.3
Interferon-induced protein with tetratricopeptide repeats 1 (IFIT1) Immune response 117.2
Interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) Immune response 62.2
Sterile alpha motif domain containing 9-like (SAMD9L) Unknown 44.3
LOC341720 Unknown 24.6
Cholesterol 25-hydroxylase (CH25H) Catalytic activity 21.3
Guanylate binding protein 1(GBP1) Immune response 13.9
CD274 antigen (CD274) Immune response, cell proliferation 13.7
Nuclear receptor coactivator 7(NCOA7) Transcriptional regulation, nucleic acid metabolism 8.5
FLJ20968 Unknown 7.3
Interferon induced with helicase C domain 1 (IFIH1) Regulation of apoptosis, regulation of translation 5.6
FLJ11000 Unknown 4.5
FLJ10159 Unknown 4.4
EST sequence Unknown 4.3
Caspase 4 (CASP4) Induction of apoptosis 3.9
Interleukin 6 (IL6) B cell and T cell differentiation 3.6
EST sequence Unknown 3.6
Suppressor of cytokine signaling 2(SOCS2) Inhibition of Jak/STAT signaling 2.8
EST sequence Unknown 2.5
T-cell activation GTPase activating protein (TAGAP) GTPase activator 2.4
ADP-ribosylation factor-like 8(ARL8) GTPase 2.1

Genes had a probe set differentially expressed by more than 2-fold (p < 0.001).